Yumura W - Search Results

1

Effects of long-term treatment with mizoribine in patients with proliferative lupus nephritis.

Yumura W, Suganuma S, Uchida K, Moriyama T, Otsubo S, Takei T, Naito M, Koike M, Nitta K, Nihei H. Yumura W, et al. Clin Nephrol. 2005 Jul;64(1):28-34. doi: 10.5414/cnp64028. Clin Nephrol. 2005. PMID: 16047642

2

The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.

Moriyama T, Honda K, Nitta K, Yumura W, Nihei H. Moriyama T, et al. Among authors: yumura w. Clin Exp Nephrol. 2004 Sep;8(3):237-42. doi: 10.1007/s10157-004-0298-7. Clin Exp Nephrol. 2004. PMID: 15480901 Clinical Trial.

3

Prolonged membranous lupus nephritis with change of anti-ssDNA antibody titer and repeated renal relapse.

Yumura W, Suganuma S, Nitta K, Sano Y, Uchida K, Nihei H. Yumura W, et al. Clin Exp Nephrol. 2004 Dec;8(4):363-8. doi: 10.1007/s10157-004-0306-y. Clin Exp Nephrol. 2004. PMID: 15619038

4

The characteristics of relapse in adult-onset minimal-change nephrotic syndrome.

Takei T, Koike M, Suzuki K, Shirota S, Itabashi M, Ohtsubo S, Sugiura H, Suzuki K, Kojima C, Takahashi M, Ino J, Ogawa T, Uchida K, Tsuchiya K, Yumura W, Nitta K. Takei T, et al. Among authors: yumura w. Clin Exp Nephrol. 2007 Sep;11(3):214-217. doi: 10.1007/s10157-007-0484-5. Epub 2007 Sep 28. Clin Exp Nephrol. 2007. PMID: 17891348

5

Fatal diffuse pulmonary arterial thrombosis as a complication of nephrotic syndrome.

Matsuda A, Tsuchiya K, Yabuki Y, Naito M, Koike M, Yumura W, Nitta K. Matsuda A, et al. Among authors: yumura w. Clin Exp Nephrol. 2007 Dec;11(4):316-320. doi: 10.1007/s10157-007-0498-z. Epub 2007 Dec 21. Clin Exp Nephrol. 2007. PMID: 18085394

6

Increased serum levels of vascular endothelial growth factor in human crescentic glomerulonephritis.

Nitta K, Uchida K, Kimata N, Honda K, Horita S, Hayashi T, Ishizuka T, Kobayashi H, Kawashima A, Yumura W, Nihei H. Nitta K, et al. Among authors: yumura w. Clin Nephrol. 1999 Aug;52(2):76-82. Clin Nephrol. 1999. PMID: 10480217

7

Evaluation of prognostic factors for myeloperoxidase anti-neutrophil cytoplasmic antibody- (MPO-ANCA) associated glomerulonephritis.

Okano K, Yumura W, Nitta K, Honda K, Uchida K, Nihei H. Okano K, et al. Among authors: yumura w. Clin Nephrol. 2001 Apr;55(4):275-81. Clin Nephrol. 2001. PMID: 11334312

8

Analysis of lupus activity in end-stage renal disease treated by hemodialysis.

Okano K, Yumura W, Nitta K, Uchida K, Ohnuki T, Kawashima A, Nihei H. Okano K, et al. Among authors: yumura w. Intern Med. 2001 Jul;40(7):598-602. doi: 10.2169/internalmedicine.40.598. Intern Med. 2001. PMID: 11506299 Free article.

9

Tubular osteopontin expression in patients with ANCA-associated glomerulonephritis.

Nitta K, Horita S, Okano K, Uchida K, Honda K, Koike M, Sekine S, Itabashi M, Tsukada M, Takei T, Suzuki K, Yumura W, Nihei H. Nitta K, et al. Among authors: yumura w. Clin Nephrol. 2001 Dec;56(6):459-66. Clin Nephrol. 2001. PMID: 11770797

10

Mast cells and tubulointerstitial fibrosis in patients with ANCA-associated glomerulonephritis.

Otsubo S, Nitta K, Uchida K, Yumura W, Nihei H. Otsubo S, et al. Among authors: yumura w. Clin Exp Nephrol. 2003 Mar;7(1):41-7. doi: 10.1007/s101570300005. Clin Exp Nephrol. 2003. PMID: 14586742

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

188 results

Search Page

Filters